Please provide your email address to receive an email when new articles are posted on . It has become much harder to be a rational person with a modicum of biostatistical knowledge who can refrain ...
New analysis of PARTNER trial data shows that, even after extensive adjustment, there are differences in outcomes between transapical and transfemoral TAVR for high-risk and inoperable patients with ...
Medical Care, Vol. 45, No. 10, Supplement 2: Comparative Effectiveness and Safety: Emerging Methods (Oct., 2007), pp. S143-S148 (6 pages) Background: In observational research, propensity score ...
ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma. This is an ...